PGT-M for spinocerebellar ataxia type 1: development of a STR panel and a report of two clinical cases-Reference-Cited by-同舟云学术

PGT-M for spinocerebellar ataxia type 1: development of a STR panel and a report of two clinical cases

Published:2024-04-05 Issue:5 Volume:41 Page:1273-1283
ISSN:1058-0468
Container-title:Journal of Assisted Reproduction and Genetics
language:en
Short-container-title:J Assist Reprod Genet

Author:

Soloveva Elena V.^ORCID,Skleimova Maria M.^ORCID,Minaycheva Larisa I.^ORCID,Garaeva Anna F.,Zhigalina Daria I.^ORCID,Churkin Egor O.,Okkel Yulia V.,Timofeeva Oksana S.^ORCID,Petrov Ilya A.^ORCID,Seitova Gulnara N.,Lebedev Igor N.^ORCID,Stepanov Vadim A.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10815-024-03105-w.pdf

Reference33 articles.

1. Opal P, Ashizawa T. Spinocerebellar Ataxia Type 1. 1998 Oct 1 [Updated 2023 Feb 2]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle: University of Washington; 1993–2023. Bookshelf URL: https://www.ncbi.nlm.nih.gov/books/.

2. Zoghbi HY, Orr HT. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J Biol Chem. 2009;284(12):7425–9. https://doi.org/10.1074/jbc.R800041200.

3. Illarioshkin SN, Slominsky PA, Ovchinnikov IV, et al. Spinocerebellar ataxia type 1 in Russia. J Neurol. 1996;243(7):506–10. https://doi.org/10.1007/BF00886871.

4. Orr HT. Cell biology of spinocerebellar ataxia. J Cell Biol. 2012;197(2):167–77. https://doi.org/10.1083/jcb.201105092.

5. Srinivasan SR, Shakkottai VG. Moving towards therapy in SCA1: insights from molecular mechanisms, identification of novel targets, and planning for human trials. Neurotherapeutics. 2019;16(4):999–1008. https://doi.org/10.1007/s13311-019-00763-y.